Director/PDMR Shareholding and Total Voting Rights

Bellevue Healthcare Trust PLC

28 March 2024

 

Bellevue HEALTHCARE TRUST plc

LEI: 213800HQ3J3H9YF2UI82

28 March 2024

Director/PDMR Shareholding & Total Voting rights and capital

Bellevue Healthcare Trust Plc announces that the below ordinary redeemable shares have been acquired from the net directors' fees payable for the quarter ended 31 March 2024:

Director	Number of Shares purchased
J Dixon	5,993
R Grewal	8,498
P Southgate	2,843
T Young	2,843
K Bolsover	2,843

Following these transactions, the above directors' total shareholdings in the Company are as follows:

Director	Total shareholding
J Dixon	131,102
R Grewal	165,090
P Southgate	100,723
T Young	37,511
K Bolsover	31,791

Enquiries:

Apex Listed Companies Services (UK) Limited	[phone]
Company Secretary

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Josephine Dixon
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Bellevue Healthcare Trust Plc
b)	LEI	213800HQ3J3H9YF2UI82
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Redeemable Ordinary Shares
	Identification code	ISIN GB00BZCNLL95
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			151.4435p per share	5,993
d)	Aggregated information
	- Aggregated volume	5,993
	- Price	Total price £9,076.01
e)	Date of the transaction	27 March 2024
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Randeep Grewal
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Bellevue Healthcare Trust Plc
b)	LEI	213800HQ3J3H9YF2UI82
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Redeemable Ordinary Shares
	Identification code	ISIN GB00BZCNLL95
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			151.4435p per share	8,498
d)	Aggregated information
	- Aggregated volume	8,498
	- Price	Total price £12,869.67
e)	Date of the transaction	27 March 2024
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Paul Southgate
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Bellevue Healthcare Trust Plc
b)	LEI	213800HQ3J3H9YF2UI82
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Redeemable Ordinary Shares
	Identification code	ISIN GB00BZCNLL95
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			151.4435p per share	2,843
d)	Aggregated information
	- Aggregated volume	2,843
	- Price	Total price £4,305.54
e)	Date of the transaction	27 March 2024
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Tony Young
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Bellevue Healthcare Trust Plc
b)	LEI	213800HQ3J3H9YF2UI82
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Redeemable Ordinary Shares
	Identification code	ISIN GB00BZCNLL95
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			151.4435p per share	2,843
d)	Aggregated information
	- Aggregated volume	2,843
	- Price	Total price £4,305.54
e)	Date of the transaction	27 March 2024
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Kate Bolsover
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Bellevue Healthcare Trust Plc
b)	LEI	213800HQ3J3H9YF2UI82
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Redeemable Ordinary Shares
	Identification code	ISIN GB00BZCNLL95
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			151.4435p per share	2,843
d)	Aggregated information
	- Aggregated volume	2,843
	- Price	Total price £4,305.54
e)	Date of the transaction	27 March 2024
f)	Place of the transaction	London Stock Exchange

TOTAL VOTING RIGHTS AND CAPITAL

In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies the market of the following:

As at 28 March 2024, the issued share capital of the Company consists of 478,987,196 Ordinary Shares.  Of that amount, 16,698,646 Ordinary shares were held in Treasury and 462,288,550 Ordinary shares were in circulation.

Therefore, the total number of voting rights in the Company is 462,288,550 (the 'Figure').

This Figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

For further information please contact:

Apex Listed Companies Services (UK) Limited
Company Secretary
0203 327 9720

END

 

END